The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases.
Open accessAbstract
A human epithelial (HeLa) cDNA library was screened with degenerate oligonucleotides designed to hybridize to highly conserved regions of protein-tyrosine kinases. One cDNA from this screen was shown to contain a putative protein-tyrosine kinase catalytic domain and subsequently used to isolate another cDNA from a human keratinocyte library that encompasses the entire coding region of a 976-amino-acid polypeptide. The predicted protein has an external domain of 534 amino acids with a presumptive N-terminal signal peptide, a transmembrane domain, and a cytoplasmic domain of 418 amino acids that includes a canonical protein-tyrosine kinase catalytic domain. Molecular phylogeny indicates that this protein kinase is closely related to eph and elk and that this receptor family is more closely related to the non-receptor protein-tyrosine kinase families than to other receptor protein-tyrosine kinases. Antibodies raised against a TrpE fusion protein immunoprecipitated a 130-kDa protein that became phosphorylated on tyrosine in immune complex kinase assays, indicating that this protein is a bona fide protein-tyrosine kinase. Analysis of RNA from 13 adult rat organs showed that the eck gene is expressed most highly in tissues that contain a high proportion of epithelial cells, e.g., skin, intestine, lung, and ovary. Several cell lines of epithelial origin were found to express the eck protein kinase at the protein and RNA levels. Immunohistochemical analysis of several rat organs also showed staining in epithelial cells. These observations prompted us to name this protein kinase eck, for epithelial cell kinase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Self-citationKozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741 · cited 2×
“The first ATG is in a context that follows Kozak's rules (15) and is followed by what appears to be a cleavable signal sequence that includes 17 hydrophobic amino acids (29).”
BackgroundA new method for predicting signal sequence cleavage sites
von Heijne, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.11.4683 · Cited by 4,508
Cited by
Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,028
Clark, S. E., Williams, R. W., & Meyerowitz, E. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80239-1 · Cited by 1,373
THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT
Flanagan, J. G., & Vanderhaeghen, P. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.309 · Cited by 1,080
Klein, R., Nanduri, V., Jing, S., Lamballe, F., Tapley, P., Bryant, S., Cordon-Cardo, C., Jones, K. R., Reichardt, L. F., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90628-c · Cited by 958
“Moreover, they may help to identify the ligands of orphan neurogenic receptors such as the members of the elkleck family of tyrosine kinases (Letwin et al., 1988; Lindberg and Hunter, 1990; Lai and Lemke, 1991).”
BackgroundDrescher, U., Kremoser, C., Handwerker, C., Löschinger, J., Noda, M., & Bonhoeffer, F. (1995) · Cell · doi:10.1016/0092-8674(95)90425-5 · Cited by 850
Franco, B., Guioli, S., Pragliola, A., Incerti, B., Bardoni, B., Tonlorenzi, R., Carrozzo, R., Maestrini, E., Pieretti, M., Taillon-Miller, P., et al. (1991) · Nature · doi:10.1038/353529a0 · Cited by 846
O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., Prokop, C., Espinosa, R., Le Beau, M. M., Earp, H. S., & Liu, E. T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5016 · Cited by 742
Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., Pawson, T., Goldfarb, M., & Yancopoulos, G. D. (1994) · Science · doi:10.1126/science.7973638 · Cited by 710
Neurotrophin receptors: A window into neuronal differentiation
Chao, M. V. (1992) · Neuron · doi:10.1016/0896-6273(92)90023-7 · Cited by 692
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
Miao, H., Burnett, E., Kinch, M., Simon, E., & Wang, B. (2000) · Nature Cell Biology · doi:10.1038/35000008 · Cited by 548
Preclinical and clinical development of siRNA-based therapeutics
Ozcan, G., Ozpolat, B., Coleman, R. L., Sood, A. K., & Lopez-Berestein, G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.007 · Cited by 449
Lai, C., & Lemke, G. (1991) · Neuron · doi:10.1016/0896-6273(91)90167-x · Cited by 443
Axonal Protein Synthesis Provides a Mechanism for Localized Regulation at an Intermediate Target
Brittis, P. A., Lu, Q., & Flanagan, J. G. (2002) · Cell · doi:10.1016/s0092-8674(02)00813-9 · Cited by 381
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
Self-citationPartanen, J., Armstrong, E., Mäkelä, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K., & Alitalo, K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1698 · Cited by 373
Mycosis Fungoides: Disease Evolution and Prognosis of 309 Dutch Patients
van Doorn, R., Van Haselen, C. W., van Voorst Vader, P. C., Geerts, M.-L., Heule, F., de Rie, M., Steijlen, P. M., Dekker, S. K., van Vloten, W. A., & Willemze, R. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.4.504 · Cited by 367
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Miao, H., Wei, B.-R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., & Wang, B. (2001) · Nature Cell Biology · doi:10.1038/35074604 · Cited by 358
Goodwin, R. G., Din, W. S., Davis‐Smith, T., Anderson, D. M., Gimpel, S. D., Sato, T. A., Maliszewski, C. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., et al. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231037 · Cited by 334
[1] Protein kinase classification
Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)00125-g · Cited by 323
Self-citationThe EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Wykosky, J., & Debinski, W. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0244 · Cited by 300
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Wykosky, J., Gibo, D. M., Stanton, C., & Debinski, W. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0056 · Cited by 290
Prat, M., Narsimhan, R. P., Crepaldi, T., Rita Nicotra, M., Natali, P. G., & Comoglio, P. M. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490302 · Cited by 287
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., & Kinch, M. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t · Cited by 269
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Thaker, P. H., Deavers, M., Celestino, J., Thornton, A., Fletcher, M. S., Landen, C. N., Kinch, M. S., Kiener, P. A., & Sood, A. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0589 · Cited by 211
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
Han, L., Dong, Z., Qiao, Y., Kristensen, G. B., Holm, R., Nesland, J. M., & Suo, Z. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.036 · Cited by 68
Hsu, K., Middlemiss, S., Saletta, F., Gottschalk, S., McCowage, G. B., & Kramer, B. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-00221-4 · Cited by 51
EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
CHEN, P., HUANG, Y., ZHANG, B., WANG, Q., & BAI, P. (2014) · Oncology Letters · doi:10.3892/ol.2014.2093 · Cited by 30
Metadata
- Authors
- Lindberg, R. A., & Hunter, T.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-12
- Volume
- 10
- Issue
- 12
- Pages
- 6316-6324
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1768148184
- Cited by
- 257
- References
- 29
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.